Naohiro Makise
- Rheumatology top 10%
- Bone Tumor Diagnosis and Treatments 11
- Soft tissue tumor case studies 5
-
- Sarcoma Diagnosis and Treatment 20
-
- Neurofibromatosis and Schwannoma Cases 8
-
- Vascular Tumors and Angiosarcomas 5
-
- Cardiac tumors and thrombi 6
-
- Bladder and Urothelial Cancer Treatments 5
- Urinary and Genital Oncology Studies 5
- Co-authors
- Akihiko YoshidaAkira KawaiNobuyoshi HiraokaSusumu WakaiMasashi FukayamaTetsuo UshikuMasaya SekimizuHitoshi Ichikawa
- Journals
- SHILAP Revista de lepidopterología (7 papers)The American Journal of Surgical Pathology (3 papers)Human Pathology (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Naohiro Makise
35 papers receiving 397 citations
Peers
Comparison fields: 5 of 48
- Rheumatology 113
- Pulmonary and Respiratory Medicine 224
- Neurology 82
- Oncology 134
- Nephrology 25
Countries citing papers authored by Naohiro Makise
This map shows the geographic impact of Naohiro Makise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naohiro Makise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naohiro Makise more than expected).
Fields of papers citing papers by Naohiro Makise
This network shows the impact of papers produced by Naohiro Makise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naohiro Makise. The network helps show where Naohiro Makise may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naohiro Makise, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 9 | |
| 11 | 2020 | 10 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 17 | |
| 14 | 2020 | 9 | |
| 15 | 2020 | 12 | |
| 16 | 2018 | 20 | |
| 17 | 2018 | 32 | |
| 18 | 2015 | 6 | |
| 19 | 2015 | 5 | |
| 20 | 2014 | 2 |
About Naohiro Makise
Naohiro Makise is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Neurology, having authored 39 papers that have together received 399 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (20 papers), Bone Tumor Diagnosis and Treatments (11 papers), Neurofibromatosis and Schwannoma Cases (8 papers), Cardiac tumors and thrombi (6 papers), Vascular Tumors and Angiosarcomas (5 papers), Bladder and Urothelial Cancer Treatments (5 papers), Soft tissue tumor case studies (5 papers) and Urinary and Genital Oncology Studies (5 papers). The work is most often cited by research in Rheumatology (113 citations), Pulmonary and Respiratory Medicine (224 citations) and Neurology (82 citations). Naohiro Makise has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Akihiko Yoshida, Akira Kawai, Nobuyoshi Hiraoka, Susumu Wakai, Masashi Fukayama, Tetsuo Ushiku, Masaya Sekimizu, Hitoshi Ichikawa, Hiroshi Kobayashi and Ryo Kurokawa. Their work appears in journals such as SHILAP Revista de lepidopterología, The American Journal of Surgical Pathology and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.